Location: Home
  • search
  • go
  • Relate News
  • 12/5/2022Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
  • 12/2/2022CDE Issues Notice on Requirements for e-Submission of Drug Registratio...
  • 12/2/2022Catalent Expands Clinical Supply Facility in China's FTZ
  • 12/2/2022HanAll's Licensed Partner in China Enters Sublicense Agreement with CS...
  • 12/2/2022Recent Executive Moves
  • 12/2/2022China's Challenge in the Drug Services Field (C&EN)
  • 12/1/2022A Growing Number of Drugmakers in China Are on A Quest to Treat NASH (...
  • 12/1/2022Eli Lilly Dumps Innovent's PD-1 after FDA Rebuff (FiercePharma)
  • 12/1/2022NMPA Solicits Comments on the Provisions on Facilitating Main Responsi...
  • 11/30/2022WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
  • 11/30/2022NMPA Issues Appendix 6 for Quality Control of Drug Retail Delivery of ...
  • 11/30/2022NMPA Issues the Announcement on Implementation of Electronic Submissio...
  • 11/30/2022NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
  • 11/30/2022NMPA Issues the Announcement on Regulating the Filing and Reporting of...
  • 11/30/2022XJTLU and University of Liverpool to Inaugurate Joint Pharma R&D Cente...
  • 11/30/2022Financial-related Company News Digest (November 2022)
  • 11/30/2022Population Ageing in China: Crisis or Opportunity? (The Lancet)
  • 11/30/2022Nowcasting and Forecasting the Care Needs of the Older Population in C...
  • 11/30/2022Chinese Pharma Recovery Face Pressure as Covid Surges to A New Peak
  • 11/29/2022A Slow October Sees Deals in Novel Therapies with New Technologies (Ph...
  • 11/29/2022DB6: Strong Global CHC Growth Continues in MAT Q2/2022, As China Sales...
  • 11/29/2022Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
  • 11/29/2022Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agree...
  • 11/29/2022Fosun Weighs Sale of Indian Drugmaker Gland Pharma - Bloomberg
  • 11/28/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines Q5A(...
  • 11/28/2022Fosun's Wanbang and Sirona Biochem Sign New Licensing Pact for Non-Ins...
  • 11/28/2022Biocytogen Enters into Antibody Agreement with ADC Therapeutics
  • 11/28/2022Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Pep...
  • 11/28/2022India's API import from China May Fall 25% in the Next Five Years
  • 11/28/2022China Is to Begin Formal Access Negotiation for the 2022 NRDL
  • Page:134/789 Total number of articles:23668: [First][<<] [132] [133] [134] [135] [136] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group